UBS AM’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,705
| Closed | -$224K | – | 2578 |
|
|
2023
Q3 | $224K | Hold |
4,705
| – | – | ﹤0.01% | 2495 |
|
|
2023
Q2 | $534K | Hold |
4,705
| – | – | ﹤0.01% | 2296 |
|
|
2023
Q1 | $534K | Buy |
4,705
+587
| +14% | +$66.6K | ﹤0.01% | 2296 |
|
|
2022
Q4 | $461K | Hold |
4,118
| – | – | ﹤0.01% | 2201 |
|
|
2022
Q3 | $529K | Sell |
4,118
-886
| -18% | -$114K | ﹤0.01% | 2326 |
|
|
2022
Q2 | $343K | Buy |
5,004
+971
| +24% | +$66.6K | ﹤0.01% | 2432 |
|
|
2022
Q1 | $574K | Buy |
4,033
+2
| +0% | +$285 | ﹤0.01% | 2418 |
|
|
2021
Q4 | $672K | Sell |
4,031
-17,504
| -81% | -$2.92M | ﹤0.01% | 2416 |
|
|
2021
Q3 | $3M | Buy |
21,535
+17,032
| +378% | +$2.37M | ﹤0.01% | 1638 |
|
|
2021
Q2 | $2.15M | Buy |
4,503
+902
| +25% | +$430K | ﹤0.01% | 1811 |
|
|
2021
Q1 | $1.48M | Buy |
3,601
+449
| +14% | +$185K | ﹤0.01% | 1888 |
|
|
2020
Q4 | $1.54M | Buy |
+3,152
| New | +$1.54M | ﹤0.01% | 1786 |
|
|
2019
Q2 | – | Sell |
-526
| Closed | -$72.3K | – | 2869 |
|
|
2019
Q1 | $72.3K | Buy |
+526
| New | +$72.3K | ﹤0.01% | 2588 |
|
|
2016
Q4 | – | Sell |
-6,686
| Closed | -$1.64M | – | 2587 |
|
|
2016
Q3 | $1.64M | Sell |
6,686
-530
| -7% | -$130K | ﹤0.01% | 1453 |
|
|
2016
Q2 | $4.19M | Buy |
7,216
+2,788
| +63% | +$1.62M | ﹤0.01% | 1066 |
|
|
2016
Q1 | $2.35M | Buy |
4,428
+77
| +2% | +$40.9K | ﹤0.01% | 1307 |
|
|
2015
Q4 | $3.05M | Sell |
4,351
-421
| -9% | -$296K | ﹤0.01% | 1244 |
|
|
2015
Q3 | $2.83M | Buy |
4,772
+1,362
| +40% | +$807K | ﹤0.01% | 1270 |
|
|
2015
Q2 | $2.83M | Buy |
+3,410
| New | +$2.83M | ﹤0.01% | 1244 |
|